【美股焦點】近廿年首隻獲批阿茲海默症新藥 Biogen股價升近四成 – 香港經濟日報 – 即時新聞頻道 – iMoney智富 – 股樓投資 2021-06-08T03:53:19-04:00June 8th, 2021| share this article!美國食品及藥物管理局(FDA)批准Biogen(BIIB)研發的阿茲海默症新藥Aducanumab,為FDA過去20年首隻批准使用的阿茲海默症藥物。 當局要求藥物在美國推出市面後持續監察,同時要求Bi Read More share this article! Related Posts US law firm Mayer Brown to split its Hong Kong operations May 2nd, 2024 Why one of Japan’s biggest real estate projects is tapping Toyota May 2nd, 2024 Japan PM vows to lead international AI rules with new framework May 2nd, 2024 Job title inflation trend fading in Hong Kong May 2nd, 2024